US Business
Amgen Wins Approval for Pathbreaking Lung Cancer Drug
A potential blockbuster, the drug is the first to treat a common cancer mutation called KRAS that researchers struggled for years to target.
Copyright © 2023 Joplin Area Chamber of Commerce | Web Development by Storm Cloud Marketing